Evaluation of an electronic psycho-oncological adaptive screening program (EPAS) with immediate patient feedback: findings from a German cluster intervention study

Peter Esser, Leon Sautier, Susanne Sarkar, Georgia Schilling, Carsten Bokemeyer, Uwe Koch, Matthias Rose, Michael Friedrich, Sandra Nolte, Otto Walter, Anja Mehnert-Theuerkauf, Peter Esser, Leon Sautier, Susanne Sarkar, Georgia Schilling, Carsten Bokemeyer, Uwe Koch, Matthias Rose, Michael Friedrich, Sandra Nolte, Otto Walter, Anja Mehnert-Theuerkauf

Abstract

Purpose: Distress screening has become mandatory and essential in comprehensive cancer care. We evaluated an electronic psycho-oncological adaptive screening (EPAS) which assesses objective indicators of care needs and subjectively perceived care needs and subsequently provides patient feedback with individualized recommendations about psychosocial care services.

Methods: Patients were assessed within clusters, i.e., different oncological facilities of the competence network of the University Cancer Center Hamburg (UCCH). Patients in the intervention arm underwent the screening, controls received standard care. Patients were assessed at baseline (t0), 3-month (t1), and 6-month (t2) follow-up. Outcomes included information level and use of/access to nine psychosocial services at UCCH, well-being (GAD-7, PHQ-9, SF-8), and treatment satisfaction (SCCC). Conditional linear and logistic regressions were used to identify screening effects at t1 and t2.

Results: Of 1320 eligible patients across 11 clusters, 660 were included (50%). The average age was 60 years; 46% were female. The intervention was associated with increased information level for all psychosocial services at t1 and t2 (all p < .001), increased use in some of these services at t1 and t2, respectively (p ≤ .02), and better evaluation of access (e.g., more recommendations for services provided by physicians, p < .01). At t2, the intervention was associated with a lower level of satisfaction with disease-related information (p = .02).

Conclusions: EPAS may improve information about psychosocial services as well as utilization of and access to these services. The effect on information level seems not to be generalizable to other aspects of oncological care. Future studies should incorporate novel technologies and condense the procedure to its core factors.

Implications for cancer survivors: The screening may help to enhance self-management competencies among cancer survivors.

Trial registration: The trial was retrospectively registered (2/2021) at ClinicalTrials.gov (number: NCT04749056).

Keywords: Cancer; Distress; Patient-reported outcomes; Psycho-oncology; Quality of life; Screening.

Conflict of interest statement

The authors declare no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Flow chart. UCCH, University Cancer Center Hamburg. aClusters were included if they (i) were primary oncology facilities, (ii) treating a high number of patients, and (iii) agreed to participate in the study; each cluster received each condition except for the cluster “Marienkrankenhaus—Private station” which only received control condition owing to too few participants. bSevere physical/mental/cognitive impairment (n = 193), isolated (n = 18), insufficient language skills (n = 68), incompetence to use tablet as assessed by physicians (n = 9). cPhysical/mental burden (n = 32), organizational issues (n = 19), no interest (n = 171), other reasons (n = 59). dSevere physical/mental/cognitive impairment (n = 130), isolated (n = 21), insufficient language skills (n = 23), underage (n = 2). ePhysical/mental burden (n = 14), organizational issues (n = 8), no interest (n = 66), other reasons (n = 5). fWithin clearance of the final data, any cases with unrestorable documentation errors or missing/unclear information on either age, gender, or diagnosis were deleted. gPatient loss mostly due to not sending back the questionnaires or having deceased

References

    1. Hartung TJ, Brähler E, Faller H, et al. The risk of being depressed is significantly higher in cancer patients than in the general population: prevalence and severity of depressive symptoms across major cancer types. Eur J Cancer. 2017;72:46–53. doi: 10.1016/j.ejca.2016.11.017.
    1. Kuba K, Esser P, Mehnert A, et al. Risk for depression and anxiety in long-term survivors of hematologic cancer. Health psychology: official journal of the Division of Health Psychology, American Psychological Association. 2019;38:187–195. doi: 10.1037/hea0000713.
    1. Bultz BD, Carlson LE. Emotional distress: the sixth vital sign–future directions in cancer care. Psychooncology. 2006;15:93–95. doi: 10.1002/pon.1022.
    1. Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40:1797–1810. doi: 10.1017/S0033291709992285.
    1. Fallowfield, L, et al. Psychiatric morbidity and its recognition by doctors in patients with cancer.
    1. Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013;31:782–793. doi: 10.1200/JCO.2011.40.8922.
    1. Carlson LE, Waller A, Mitchell AJ. Screening for distress and unmet needs in patients with cancer: review and recommendations. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2012;30:1160–1177. doi: 10.1200/JCO.2011.39.5509.
    1. Li M, Macedo A, Crawford S, et al. Easier said than done: keys to successful implementation of the distress assessment and response tool (DART) program. Journal of oncology practice. 2016;12:e513–e526. doi: 10.1200/JOP.2015.010066.
    1. Schepers SA, Sint Nicolaas SM, Maurice-Stam H, et al. First experience with electronic feedback of the psychosocial assessment tool in pediatric cancer care. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2017;25:3113–3121. doi: 10.1007/s00520-017-3719-3.
    1. Smith SK, Rowe K, Abernethy AP. Use of an electronic patient-reported outcome measurement system to improve distress management in oncology. Palliat Support Care. 2014;12:69–73. doi: 10.1017/S1478951513000345.
    1. Schäffeler N, Pfeiffer K, Grischke EM, et al. Akzeptanz und Reliabilität eines elektronischen psychoonkologischen Screenings bei Patientinnen mit Brustkrebs: eine randomisiert-kontrollierte Studie. Psychother Psychosom Med Psychol. 2013;63:374–380. doi: 10.1055/s-0032-1333301.
    1. Zebrack B, Kayser K, Sundstrom L, et al. Psychosocial distress screening implementation in cancer care: an analysis of adherence, responsiveness, and acceptability. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015;33:1165–1170. doi: 10.1200/JCO.2014.57.4020.
    1. Mitchell AJ. Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncol. 2013;52:216–224. doi: 10.3109/0284186X.2012.745949.
    1. Carlson LE. Screening alone is not enough: the importance of appropriate triage, referral, and evidence-based treatment of distress and common problems. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013;31:3616–3617. doi: 10.1200/JCO.2013.51.4315.
    1. McCarter K, Britton B, Baker AL, et al. Interventions to improve screening and appropriate referral of patients with cancer for psychosocial distress: systematic review. BMJ open 2018 8.
    1. Singer S, Danker H, Roick J, et al. Effects of stepped psychooncological care on referral to psychosocial services and emotional well-being in cancer patients: a cluster-randomized phase III trial. Psychooncology. 2017;26:1675–1683. doi: 10.1002/pon.4492.
    1. Martin A, Rief W, Klaiberg A, Braehler E. Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. Gen Hosp Psychiatry. 2006;28:71–77. doi: 10.1016/j.genhosppsych.2005.07.003.
    1. Löwe B, Decker O, Müller S, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Medical care 2008:266–74.
    1. Fischer HF, Klug C, Roeper K, et al. Screening for mental disorders in heart failure patients using computer-adaptive tests. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2014;23:1609–1618. doi: 10.1007/s11136-013-0599-y.
    1. Faller H, Weis J, Koch U, et al. Perceived need for psychosocial support depending on emotional distress and mental comorbidity in men and women with cancer. J Psychosom Res. 2016;81:24–30. doi: 10.1016/j.jpsychores.2015.12.004.
    1. Fliege H, Becker J, Walter OB, Rose M, Bjorner JB, Klapp BF. Evaluation of a computer-adaptive test for the assessment of depression (D-CAT) in clinical application. Int J Methods Psychiatr Res. 2009;18:23–36. doi: 10.1002/mpr.274.
    1. Becker J, Fliege H, Kocalevent R-D, et al. Functioning and validity of A computerized adaptive test to measure anxiety (A-CAT) Depress Anxiety. 2008;25:E182–E194. doi: 10.1002/da.20482.
    1. Kocalevent R-D, Rose M, Becker J, et al. An evaluation of patient-reported outcomes found computerized adaptive testing was efficient in assessing stress perception. J Clin Epidemiol. 2009;62:278–287. doi: 10.1016/j.jclinepi.2008.03.003.
    1. Wahl I, Löwe B, Bjorner JB, et al. Standardization of depression measurement: a common metric was developed for 11 self-report depression measures. J Clin Epidemiol. 2014;67:73–86. doi: 10.1016/j.jclinepi.2013.04.019.
    1. Ellert U, Lampert T, Ravens-Sieberer U. Messung der gesundheitsbezogenen Lebensqualität mit dem SF-8. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 2005 48:1330-7.
    1. Esser P, Sautier L, Sarkar S, et al. Development and preliminary psychometric investigation of the German satisfaction with comprehensive cancer care (SCCC) questionnaire. Health Qual Life Outcomes. 2021;19:147. doi: 10.1186/s12955-021-01784-y.
    1. Mehnert A, Müller D, Lehmann C, Koch U. Die deutsche version des NCCN distress-thermometers: empirische Prüfung eines screening-instruments zur erfassung psychosozialer belastung bei krebspatienten. Z Psychiatr Psychol Psychother. 2006;54:213–223.
    1. Andrade C. Understanding relative risk, odds ratio, and related terms: as simple as it can get. J Clin Psychiatry. 2015;76:857–861. doi: 10.4088/JCP.15f10150.
    1. Dinkel A, Berg P, Pirker C, et al. Routine psychosocial distress screening in radiotherapy: implementation and evaluation of a computerised procedure. Br J Cancer. 2010;103:1489–1495. doi: 10.1038/sj.bjc.6605930.
    1. Warrington L, Absolom K, Conner M, et al. Electronic systems for patients to report and manage side effects of cancer treatment: systematic review. J Med Internet Res. 2019;21:e10875. doi: 10.2196/10875.
    1. Fridriksdottir N, Gunnarsdottir S, Zoëga S, Ingadottir B, Hafsteinsdottir EJG. Effects of web-based interventions on cancer patients' symptoms: review of randomized trials. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2018;26:337–351. doi: 10.1007/s00520-017-3882-6.
    1. van der Hout A, van Uden-Kraan CF, Holtmaat K, et al. Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial. Lancet Oncol. 2020;21:80–94. doi: 10.1016/S1470-2045(19)30675-8.
    1. van der Hout A, Holtmaat K, Jansen F, et al. The eHealth self-management application ‘Oncokompas’ that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most? Acta oncologica (Stockholm, Sweden) 2021;60:403–411. doi: 10.1080/0284186X.2020.1851764.
    1. Nemes S, Jonasson JM, Genell A, Steineck G. Bias in odds ratios by logistic regression modelling and sample size. BMC Med Res Methodol. 2009;9:56. doi: 10.1186/1471-2288-9-56.
    1. van Ploos Amstel FK, Peters MEWJ, Donders R, et al. Does a regular nurse-led distress screening and discussion improve quality of life of breast cancer patients treated with curative intent? A randomized controlled trial Psycho-Oncology. 2020;29:719–728. doi: 10.1002/pon.5324.
    1. Hollingworth W, Metcalfe C, Mancero S, et al. Are needs assessments cost effective in reducing distress among patients with cancer? A randomized controlled trial using the distress thermometer and problem list. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2013;31:3631–3638. doi: 10.1200/JCO.2012.48.3040.
    1. van der Meulen I, May A, Koole R, Ros W. A distress thermometer intervention for patients with head and neck cancer. ONF. 2018;45:E14–E32. doi: 10.1188/18.ONF.E14-E32.
    1. Braeken APBM, Kempen GIJM, Eekers DBP, et al. Psychosocial screening effects on health-related outcomes in patients receiving radiotherapy. A cluster randomised controlled trial Psycho-oncology. 2013;22:2736–2746. doi: 10.1002/pon.3340.
    1. Mertz BG, Dunn-Henriksen AK, Kroman N, et al. The effects of individually tailored nurse navigation for patients with newly diagnosed breast cancer: a randomized pilot study. Acta Oncol. 2017;56:1682–1689. doi: 10.1080/0284186X.2017.1358462.
    1. Meijer A, Roseman M, Delisle VC, et al. Effects of screening for psychological distress on patient outcomes in cancer: a systematic review. J Psychosom Res. 2013;75:1–17. doi: 10.1016/j.jpsychores.2013.01.012.
    1. Rankin NM, Butow PN, Thein T, et al. Everybody wants it done but nobody wants to do it: an exploration of the barrier and enablers of critical components towards creating a clinical pathway for anxiety and depression in cancer. BMC Health Serv Res. 2015;15:28. doi: 10.1186/s12913-015-0691-9.
    1. Geerligs L, Shepherd HL, Butow P, et al. What factors influence organisational readiness for change? Implementation of the Australian clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP) Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2020 doi: 10.1007/s00520-020-05836-9.

Source: PubMed

3
Abonner